<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02161120</url>
  </required_header>
  <id_info>
    <org_study_id>BSTN-2014-rye</org_study_id>
    <nct_id>NCT02161120</nct_id>
  </id_info>
  <brief_title>Effect of Two Different Rye Bread Types in Irritable Bowel Syndrome</brief_title>
  <official_title>Effects of Traditional and Low-FODMAP Rye Bread in Irritable Bowel Syndrome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oy Karl Fazer Ab</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oy Karl Fazer Ab</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate if low-FODMAP (Fermented Oligo-, Di-,&#xD;
      Monosaccharides And Polyols) rye bread is better tolerated in irritable bowel syndrome than&#xD;
      commonly available traditional rye bread higher in FODMAP carbohydrates. The study also aims&#xD;
      to investigate patients' compliance to rye bread regimen, potential changes is gut microbiota&#xD;
      and hydrogen production during the test periods (a marker of large bowel fermentation of&#xD;
      poorly absorbed carbohydrates).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change is IBS symptoms by using IBS-SSS questionaire</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>IBS quality of life by using IBS QoL questionnaire</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in specific IBS symptoms measured by 100 mm VAS scale</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes is intestinal microbiota evaluated by fecal samples</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in hydrogen excretion evaluated by 6 hours breath test after standard rye bread breakfast</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">87</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Traditional rye bread</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>As part of habitual diet participants are expected to consume 100-200 grams of traditional Finnish rye bread daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-FODMAP rye bread</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>As part of habitual diet participants are expected to consume 100-200 grams of low-FODMAP rye bread daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Traditional Finnish rye bread</intervention_name>
    <arm_group_label>Traditional rye bread</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low FODMAP rye bread</intervention_name>
    <arm_group_label>Low-FODMAP rye bread</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  IBS according to Rome III criteria. Accepted sub-types include IBS-M, IBS-D and IBS-U&#xD;
&#xD;
          -  Age 18-65 years&#xD;
&#xD;
          -  Willing to use rye bread daily during the study periods&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  IBS-C (constipation dominant)&#xD;
&#xD;
          -  Celiac disease&#xD;
&#xD;
          -  IBD&#xD;
&#xD;
          -  Major gastrointestinal operations like bowel gastric resection&#xD;
&#xD;
          -  Non-treated hypo- or hyperthyroidism&#xD;
&#xD;
          -  Alcoholism, severe depression, dementia, cancer or other diseases likely to severly&#xD;
             impair the participants ability to conclude the protocol&#xD;
&#xD;
          -  Regular (almost daily) use of NSAIDs, antibiotics or lactulose&#xD;
&#xD;
          -  Linaclotide and other prescription medicines targeted specifically to IBS&#xD;
&#xD;
          -  Pregnancy and lactation&#xD;
&#xD;
          -  Follows currently strict low-FODMAP diet&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Aava Medical Centre</name>
      <address>
        <city>Helsinki</city>
        <zip>00100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>June 10, 2014</study_first_submitted>
  <study_first_submitted_qc>June 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2014</study_first_posted>
  <last_update_submitted>March 28, 2015</last_update_submitted>
  <last_update_submitted_qc>March 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 31, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IBS, irritable bowel syndrome, functional gastrointestinal disorder, diet, bread, rye, FODMAP, microbiota</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>September 26, 2016</submitted>
    <returned>November 14, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

